Get informed about the latest pancreatic cancer research advancements and milestones, Lustgarten Foundation news, and other relevant topics
and resources for patients, survivors, and caregivers.
By Vanessa Steil - April 3, 2020 We are pleased to announce the addition of Andrew Rakeman, Ph.D., our new Vice President of Research. Andy comes to the Foundation after spending 13 years at the Juvenile Diabetes Research Foundation (JDRF), where he was the Assistant Vice President of Research overseeing research programs and international partnerships [...]
By Vanessa Steil- March 26, 2020 Since the novel coronavirus, COVID-19, was officially declared a pandemic, more and more states across the country are asking people to stay home to help flatten the curve and prevent overwhelming hospitals. But for pancreatic cancer patients, this news may seem incredibly alarming, especially when actively undergoing treatment and [...]
By Vanessa Steil- February 25, 2020 What does artificial intelligence (AI) have to do with pancreatic cancer research? It turns out, a lot. AI refers to machines programmed to mimic human reasoning with the goal of learning from failure and providing the best recommendation for a specific subject. In the case of pancreatic cancer, a [...]
Pancreatic cancer research has shown that genetic testing is critical because genetics play a role in up to 10 percent of pancreatic cancer cases. However, family members of pancreatic cancer patients often are not aware that certain genetic mutations can be passed down, which is why having information about genetic risk is so important. The [...]
By Vanessa Steil- January 21, 2020 January is Pancreatic Cancer Clinical Trials Awareness Month. Clinical trials are important for delivering innovative and potentially life-saving new treatment options to patients. They may investigate new combinations of currently available drugs or study new treatments that have worked in other cancers. Through clinical trials, researchers can determine if [...]
According to the National Comprehensive Cancer Network (NCCN)’s 2019 Clinical Practice Guidelines, all pancreatic cancer patients should undergo genetic or germline testing for inherited genetic mutations, regardless of family history. Under these new recommendations, this testing should be done by a physician and the cost should be covered by insurance. The Lustgarten Foundation also encourages [...]
By Vanessa Steil- December 2, 2019 Have you or has a loved one had a pancreatic cancer diagnosis? It’s estimated that more than 56,000 Americans will be diagnosed this year alone, and the five-year survival rate remains in the single digits. The Lustgarten Foundation is the world’s largest private funder of pancreatic cancer research and [...]
In this article, Dr. Ralph Hruban answers questions about familial pancreatic cancer. Dr. Ralph Hruban is a Professor of Pathology and Oncology. Read here insights here.
About Our Expert: Elizabeth M. Jaffee, M.D., is an internationally recognized expert in pancreatic cancer and immunotherapy research. She is the Deputy Director at the Sidney Kimmel Cancer Center at Johns Hopkins and an Associate Director of the Bloomberg-Kimmel Institute for Immunotherapy. Dr. Jaffee serves as the Chief Medical Advisor for the Lustgarten Foundation as [...]
Immunotherapy is touted as the pancreatic cancer treatment option of the future. It involves using a person’s own immune system to fight and destroy cancer cells and is considered by many leading researchers to represent the future of cancer treatment. While immunotherapy has been successful in treating other diseases, only recently have we made breakthroughs [...]